Heparin-platelet factor 4 antibodies are frequent after vascular surgery but are not a frequent cause of graft thrombosis or thrombocytopenia.

[1]  A. Leo,et al.  Laboratory Diagnosis of Heparin-Induced Thrombocytopenia and Monitoring of Alternative Anticoagulants , 2003, Clinical Diagnostic Laboratory Immunology.

[2]  R. Galland.  Inflow Disease: An Under-Recognised Cause of Infra-Inguinal Graft Failure? , 2002, Cardiovascular surgery.

[3]  L. Rice,et al.  Delayed-Onset Heparin-Induced Thrombocytopenia , 2002, Annals of Internal Medicine.

[4]  M. Poncz,et al.  Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA. , 2001, Blood.

[5]  J. Kelton,et al.  Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis , 2001, Annals of Internal Medicine.

[6]  J. Kelton,et al.  Temporal aspects of heparin-induced thrombocytopenia. , 2001, The New England journal of medicine.

[7]  T. Baglin,et al.  Heparin induced thrombocytopenia thrombosis (HIT/T) syndrome: diagnosis and treatment , 2001, Journal of clinical pathology.

[8]  P. Eichler,et al.  A prospective study on the incidence and clinical relevance of heparin-induced antibodies in patients after vascular surgery. , 2000, Thrombosis research.

[9]  T. Liem,et al.  The role of heparin-associated antiplatelet antibodies in the outcome of arterial reconstruction. , 1999, Journal of vascular surgery.

[10]  Cohen Dj,et al.  Heparin-Induced Thrombocytopenia and Thrombosis , 2019 .

[11]  D. Gillespie,et al.  The incidence of heparin-induced antibodies in patients undergoing vascular surgery: a prospective study. , 1998, Journal of vascular surgery.

[12]  B. Chong,et al.  Heparin-induced Thrombocytopenia: Towards Consensus , 1998, Thrombosis and Haemostasis.

[13]  L. Cancio,et al.  Heparin-induced thrombocytopenia and thrombosis. , 1998, Journal of the American College of Surgeons.

[14]  P. Koudstaal,et al.  Heparin‐induced thrombocytopenia and thrombosis: a prospective analysis of the incidence in patients with heart and cerebrovascular diseases , 1997, British journal of haematology.

[15]  J. Kelton,et al.  The epitope specificity of heparin‐induced thrombocytopenia , 1996, British journal of haematology.

[16]  J. Hirsh,et al.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. , 1995, The New England journal of medicine.

[17]  J. Kelton,et al.  Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. , 1994, Blood.

[18]  J. Kelton,et al.  Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. , 1994, Blood.

[19]  W. Pearce,et al.  Long-Term Results in Vascular Surgery , 1993 .

[20]  J. Amiral,et al.  Platelet Factor 4 Complexed to Heparin Is the Target for Antibodies Generated in Heparin-Induced Thrombocytopenia , 1992, Thrombosis and Haemostasis.

[21]  G. Seabrook,et al.  Experience with in situ saphenous vein bypasses during 1981 to 1989: determinant factors of long-term patency. , 1991, Journal of vascular surgery.

[22]  J. Mills,et al.  The importance of routine surveillance of distal bypass grafts with duplex scanning: a study of 379 reversed vein grafts. , 1990, Journal of vascular surgery.

[23]  I. Rutkow,et al.  An analysis of vascular surgical manpower requirements and vascular surgical rates in the United States. , 1986, Journal of vascular surgery.

[24]  G. Born,et al.  The aggregation of blood platelets , 1963, The Journal of physiology.